<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="157580">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01048242</url>
  </required_header>
  <id_info>
    <org_study_id>804640</org_study_id>
    <nct_id>NCT01048242</nct_id>
  </id_info>
  <brief_title>Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)</brief_title>
  <official_title>Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Takeda</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to determine if treatment with Ramelteon will help to improve
      insomnia in older adults with co-existent insomnia and sleep apnea. The primary study
      objective is sleep latency (a measure of insomnia). The hypothesis is that sleep latency
      will be reduced in subjects taking Ramelteon relative to the placebo arm. The secondary
      study objective is to determine if subject compliance with CPAP treatment of their sleep
      apnea is improved in subjects taking Ramelteon (their compliance may be improved because
      they would have less insomnia due to Ramelteon treatment when using their CPAP). The
      hypothesis is that compliance with CPAP will be improved in subjects taking Ramelteon
      relative to the placebo arm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, double-blind, placebo-controlled, parallel arm clinical trial with two study
      arms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sleep onset latency</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Insomnia</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Ramelteon</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ramelteon 8 mg oral before bedtime</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rozerem</intervention_name>
    <description>Ramelteon (rozerem) 8mg oral before bedtime</description>
    <arm_group_label>Ramelteon</arm_group_label>
    <other_name>Ramelteon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>sugar pill</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obstructive sleep apnea

          -  Insomnia

          -  Age&gt;60

        Exclusion Criteria:

          -  Cognitive impairment

          -  Active alcohol or substance abuse

          -  Active use of other sedative-hypnotic agents

          -  Active use of fluvoxamine (drug interaction with Ramelteon

          -  Evidence of hepatic dysfunction (Ramelteon contraindicated) on liver function panel

          -  Presence of Periodic Limb Movement Disorder or Restless Legs Syndrome

          -  Severe COPD
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nalaka Gooneratne, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <lastchanged_date>January 11, 2010</lastchanged_date>
  <firstreceived_date>April 15, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Nalaka Gooneratne, MD, MSc / Assistant Professor of Medicine</name_title>
    <organization>University of Pennsylvania School of Medicine</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
